Recombinant IL6 (Olokizumab Biosimilar) antibody

Catalog No. ABIN7676038

The Human Monoclonal anti-IL6 (Olokizumab Biosimilar) antibody has been validated for ELISA, BLI, FACS, Func and SPR. It is suitable to detect IL6 (Olokizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL6 (Olokizumab Biosimilar) antibody (ABIN7676038)

Target: IL6 (Olokizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL6 (Olokizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-IL6 (Olokizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-IL-6 / IFNb2 Reference Antibody (olokizumab)

Characteristics: Anti-IL-6 / IFNb2 Reference Antibody (olokizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for IL6 (Olokizumab Biosimilar)

Target: IL6 (Olokizumab Biosimilar)

Alternative Name: IL-6 (Olokizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P05231